2-[2-(5-methylspiro[2-oxa-5-azabicyclo[10.4.0]hexadeca-1(16),12,14-triene-7,4'-piperidine]-1'-yl)-2-oxoethoxy]acetic acid

C23H34N2O5 — CID 110072297

IUPAC2-[2-(5-methylspiro[2-oxa-5-azabicyclo[10.4.0]hexadeca-1(16),12,14-triene-7,4'-piperidine]-1'-yl)-2-oxoethoxy]acetic acid
SMILESCN1CCOc2ccccc2CCCCC2(CCN(C(=O)COCC(=O)O)CC2)C1
InChIInChI=1S/C23H34N2O5/c1-24-14-15-30-20-8-3-2-6-19(20)7-4-5-9-23(18-24)10-12-25(13-11-23)21(26)16-29-17-22(27)28/h2-3,6,8H,4-5,7,9-18H2,1H3,(H,27,28)
InChIKeyFSWWTPKEDNSHHK-UHFFFAOYSA-N
MW418.53 g/mol
LogP2.43
Rot. Bonds4

About 2-[2-(5-methylspiro[2-oxa-5-azabicyclo[10.4.0]hexadeca-1(16),12,14-triene-7,4'-piperidine]-1'-yl)-2-oxoethoxy]acetic acid

2-[2-(5-methylspiro[2-oxa-5-azabicyclo[10.4.0]hexadeca-1(16),12,14-triene-7,4'-piperidine]-1'-yl)-2-oxoethoxy]acetic acid (PubChem CID 110072297) has the molecular formula C23H34N2O5 and a molecular weight of 418.53 g/mol. Its IUPAC name is 2-[2-(5-methylspiro[2-oxa-5-azabicyclo[10.4.0]hexadeca-1(16),12,14-triene-7,4'-piperidine]-1'-yl)-2-oxoethoxy]acetic acid.

Molecular Properties

Compound Name2-[2-(5-methylspiro[2-oxa-5-azabicyclo[10.4.0]hexadeca-1(16),12,14-triene-7,4'-piperidine]-1'-yl)-2-oxoethoxy]acetic acid
PubChem CID110072297
Molecular FormulaC23H34N2O5
Molecular Weight418.53 g/mol
Exact Mass418.25
IUPAC Name2-[2-(5-methylspiro[2-oxa-5-azabicyclo[10.4.0]hexadeca-1(16),12,14-triene-7,4'-piperidine]-1'-yl)-2-oxoethoxy]acetic acid
SMILESCN1CCOc2ccccc2CCCCC2(CCN(C(=O)COCC(=O)O)CC2)C1
InChIInChI=1S/C23H34N2O5/c1-24-14-15-30-20-8-3-2-6-19(20)7-4-5-9-23(18-24)10-12-25(13-11-23)21(26)16-29-17-22(27)28/h2-3,6,8H,4-5,7,9-18H2,1H3,(H,27,28)
InChIKeyFSWWTPKEDNSHHK-UHFFFAOYSA-N
XLogP2.43
TPSA79.31 Ų
H-Bond Donors1
H-Bond Acceptors5
Rotatable Bonds4
Heavy Atoms30
Complexity

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500418.53
LogP ≤ 52.43
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 105

Analyze 2-[2-(5-methylspiro[2-oxa-5-azabicyclo[10.4.0]hexadeca-1(16),12,14-triene-7,4'-piperidine]-1'-yl)-2-oxoethoxy]acetic acid with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 2-[2-(5-methylspiro[2-oxa-5-azabicyclo[10.4.0]hexadeca-1(16),12,14-triene-7,4'-piperidine]-1'-yl)-2-oxoethoxy]acetic acid?
The IUPAC name of 2-[2-(5-methylspiro[2-oxa-5-azabicyclo[10.4.0]hexadeca-1(16),12,14-triene-7,4'-piperidine]-1'-yl)-2-oxoethoxy]acetic acid (CID 110072297) is 2-[2-(5-methylspiro[2-oxa-5-azabicyclo[10.4.0]hexadeca-1(16),12,14-triene-7,4'-piperidine]-1'-yl)-2-oxoethoxy]acetic acid.
What is the SMILES notation for 2-[2-(5-methylspiro[2-oxa-5-azabicyclo[10.4.0]hexadeca-1(16),12,14-triene-7,4'-piperidine]-1'-yl)-2-oxoethoxy]acetic acid?
The canonical SMILES for 2-[2-(5-methylspiro[2-oxa-5-azabicyclo[10.4.0]hexadeca-1(16),12,14-triene-7,4'-piperidine]-1'-yl)-2-oxoethoxy]acetic acid is CN1CCOc2ccccc2CCCCC2(CCN(C(=O)COCC(=O)O)CC2)C1.
What is the InChIKey of 2-[2-(5-methylspiro[2-oxa-5-azabicyclo[10.4.0]hexadeca-1(16),12,14-triene-7,4'-piperidine]-1'-yl)-2-oxoethoxy]acetic acid?
The InChIKey is FSWWTPKEDNSHHK-UHFFFAOYSA-N. The full InChI is InChI=1S/C23H34N2O5/c1-24-14-15-30-20-8-3-2-6-19(20)7-4-5-9-23(18-24)10-12-25(13-11-23)21(26)16-29-17-22(27)28/h2-3,6,8H,4-5,7,9-18H2,1H3,(H,27,28).
What are the key properties of 2-[2-(5-methylspiro[2-oxa-5-azabicyclo[10.4.0]hexadeca-1(16),12,14-triene-7,4'-piperidine]-1'-yl)-2-oxoethoxy]acetic acid?
2-[2-(5-methylspiro[2-oxa-5-azabicyclo[10.4.0]hexadeca-1(16),12,14-triene-7,4'-piperidine]-1'-yl)-2-oxoethoxy]acetic acid has a molecular weight of 418.53 g/mol, XLogP of 2.43, 4 rotatable bonds, 1 hydrogen bond donors, and 5 hydrogen bond acceptors.
Where does this data come from?
All data for 2-[2-(5-methylspiro[2-oxa-5-azabicyclo[10.4.0]hexadeca-1(16),12,14-triene-7,4'-piperidine]-1'-yl)-2-oxoethoxy]acetic acid is sourced from PubChem (CID 110072297), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).